444 related articles for article (PubMed ID: 25356031)
21. Food and symptom generation in functional gastrointestinal disorders: physiological aspects.
Farré R; Tack J
Am J Gastroenterol; 2013 May; 108(5):698-706. PubMed ID: 23458851
[TBL] [Abstract][Full Text] [Related]
22. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension.
Gunnarsdottir SA; Sadik R; Shev S; Simrén M; Sjövall H; Stotzer PO; Abrahamsson H; Olsson R; Björnsson ES
Am J Gastroenterol; 2003 Jun; 98(6):1362-70. PubMed ID: 12818282
[TBL] [Abstract][Full Text] [Related]
23. Changes of Intestinal Functions in Liver Cirrhosis.
Fukui H; Wiest R
Inflamm Intest Dis; 2016 Apr; 1(1):24-40. PubMed ID: 29922655
[TBL] [Abstract][Full Text] [Related]
24. Corticotropin-releasing factor is present in intestinal tissue of patients with gastrointestinal dysfunction following shock and abdominal surgery.
Hill LT; Kidson SH; Michell WL
Nutrition; 2013 Apr; 29(4):650-4. PubMed ID: 23466050
[TBL] [Abstract][Full Text] [Related]
25. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites.
Pérez-Paramo M; Muñoz J; Albillos A; Freile I; Portero F; Santos M; Ortiz-Berrocal J
Hepatology; 2000 Jan; 31(1):43-8. PubMed ID: 10613726
[TBL] [Abstract][Full Text] [Related]
26. Early-life malnutrition causes gastrointestinal dysmotility that is sexually dimorphic.
Soni KG; Dike PN; Suh JH; Halder T; Edwards PT; Foong JPP; Conner ME; Preidis GA
Neurogastroenterol Motil; 2020 Dec; 32(12):e13936. PubMed ID: 33021011
[TBL] [Abstract][Full Text] [Related]
27. Role of motility measurements in managing upper gastrointestinal dysfunction.
Snape WJ
Gastroenterologist; 1998 Mar; 6(1):44-59. PubMed ID: 9531116
[TBL] [Abstract][Full Text] [Related]
28. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function.
Madrid AM; Hurtado C; Venegas M; Cumsille F; Defilippi C
Am J Gastroenterol; 2001 Apr; 96(4):1251-5. PubMed ID: 11316178
[TBL] [Abstract][Full Text] [Related]
29. Ghrelin: a gut hormonal basis of motility regulation and functional dyspepsia.
Ogiso K; Asakawa A; Amitani H; Inui A
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():67-72. PubMed ID: 21443713
[TBL] [Abstract][Full Text] [Related]
30. The effects of physical and psychological stress on the gastro-intestinal tract: lessons from animal models.
Caso JR; Leza JC; Menchén L
Curr Mol Med; 2008 Jun; 8(4):299-312. PubMed ID: 18537637
[TBL] [Abstract][Full Text] [Related]
31. [Clinical aspects, pathophysiology, diagnosis and therapy of gastrointestinal manifestations of progressive systemic scleroderma].
Folwaczny C; Voderholzer W; Riepl RL; Schindlbeck N
Z Gastroenterol; 1996 Aug; 34(8):497-508. PubMed ID: 8967123
[TBL] [Abstract][Full Text] [Related]
32. Nutritional status and gastrointestinal symptoms in systemic sclerosis patients.
Murtaugh MA; Frech TM
Clin Nutr; 2013 Feb; 32(1):130-5. PubMed ID: 22770637
[TBL] [Abstract][Full Text] [Related]
33. Intestinal epithelial barrier and neuromuscular compartment in health and disease.
D'Antongiovanni V; Pellegrini C; Fornai M; Colucci R; Blandizzi C; Antonioli L; Bernardini N
World J Gastroenterol; 2020 Apr; 26(14):1564-1579. PubMed ID: 32327906
[TBL] [Abstract][Full Text] [Related]
34. Corticotropin-releasing factor: a possible key to gut dysfunction in the critically ill.
Hill LT; Kidson SH; Michell WL
Nutrition; 2013; 29(7-8):948-52. PubMed ID: 23484741
[TBL] [Abstract][Full Text] [Related]
35. [Relationships between ascitic bacterial DNA and plasma endotoxin, gut flora and intestinal permeability in cirrhotic patients].
Jiang CY; Wang BE; Wang JC
Zhonghua Gan Zang Bing Za Zhi; 2008 Aug; 16(8):594-8. PubMed ID: 18752746
[TBL] [Abstract][Full Text] [Related]
36. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.
Giannelli V; Di Gregorio V; Iebba V; Giusto M; Schippa S; Merli M; Thalheimer U
World J Gastroenterol; 2014 Dec; 20(45):16795-810. PubMed ID: 25492994
[TBL] [Abstract][Full Text] [Related]
37. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients.
Alvares-da-Silva MR; Reverbel da Silveira T
Nutrition; 2005 Feb; 21(2):113-7. PubMed ID: 15723736
[TBL] [Abstract][Full Text] [Related]
38. Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disorders.
Sanger GJ; Lee K
Nat Rev Drug Discov; 2008 Mar; 7(3):241-54. PubMed ID: 18309313
[TBL] [Abstract][Full Text] [Related]
39. Evolving concepts in the cellular control of gastrointestinal motility: neurogastroenterology and enteric sciences.
Mazzone A; Farrugia G
Gastroenterol Clin North Am; 2007 Sep; 36(3):499-513, vii. PubMed ID: 17950435
[TBL] [Abstract][Full Text] [Related]
40. Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update.
Fukui H
Gut Liver; 2021 Sep; 15(5):666-676. PubMed ID: 33071239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
